Ausgabe 11/2023
Including Invited Review on A paradigm shift in the treatment of resectable gastrointestinal cancer
Inhalt (15 Artikel)
Perioperative immune checkpoint inhibitor therapy for gastric and gastroesophageal junction cancers: a review of current approaches and future perspectives
Daisuke Takahari, Izuma Nakayama
Immune checkpoint inhibitor therapy in neoadjuvant and adjuvant treatment for cancer: A paradigm shift in the treatment of resectable gastrointestinal cancer 3)A paradigm shift in the treatment of colorectal cancer
Kotoe Oshima, Kentaro Yamazaki
Oncology drug lag in Japan: has it improved over the last decade?
Yoshifumi Tachibana, Mamoru Narukawa
The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer
Lei Dai, Weibin Hu, Han Jiang, Yingchun Wang, Qi Le, Xianjiang Wu, Xiaodan Meng
Circ_0000419 acts as a tumor suppressor in gastric cancer development via regulating miR-300/RGMB axis
Jiajun Lu, Yuan Zhou, Zhiheng Chen, Honggang Jiang, Jin Li, Guangjian Dou
Correction to: Circ_0000419 acts as a tumor suppressor in gastric cancer development via regulating miR‑300/RGMB axis
Jiajun Lu, Yuan Zhou, Zhiheng Chen, Honggang Jiang, Jin Li, Guangjian Dou
Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model
Zhenkun Zhang, Qiujing Li, Shanshan Sun, Zhe Li, ZhengGuo Cui, Qian Liu, Yujie Zhang, Sili Xiong, Shukun Zhang
Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer
Kazuhiro Nishikawa, Hisato Kawakami, Toshio Shimokawa, Kazumasa Fujitani, Shigeyuki Tamura, Shunji Endo, Michiya Kobayashi, Junji Kawada, Yukinori Kurokawa, Akira Tsuburaya, Takaki Yoshikawa, Junichi Sakamoto, Taroh Satoh
Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapy
Ken Kamata, Mamoru Takenaka, Naoshi Nishida, Akane Hara, Yasuo Otsuka, Hidekazu Tanaka, Shunsuke Omoto, Kosuke Minaga, Kentaro Yamao, Yasutaka Chiba, Kazuko Sakai, Kazuto Nishio, Tomohiro Watanabe, Masatoshi Kudo
Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trial
Hiroto Kayashima, Shinji Itoh, Mototsugu Shimokawa, Hiromitsu Hayashi, Hiroshi Takamori, Kengo Fukuzawa, Mizuki Ninomiya, Kenichiro Araki, Yo-ichi Yamashita, Keishi Sugimachi, Hideaki Uchiyama, Yuji Morine, Tohru Utsunomiya, Tadashi Uwagawa, Takashi Maeda, Hideo Baba, Tomoharu Yoshizumi
Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old
Mizuki Kobayashi, Kazuyuki Numakura, Shingo Hatakeyama, Toshiya Ishida, Atsushi Koizumi, Kazuki Tadachi, Ryoma Igarashi, Koichiro Takayama, Yumina Muto, Yuya Sekine, Ryuta Sobu, Hajime Sasagawa, Hideo Akashi, Soki Kashima, Ryohei Yamamoto, Taketoshi Nara, Mitsuru Saito, Shintaro Narita, Chikara Ohyama, Tomonori Habuchi
Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group
Shigemitsu Horie, Sei Naito, Shingo Hatakeyama, Shuya Kandori, Kazuyuki Numakura, Renpei Kato, Tomoyuki Koguchi, Shingo Myoen, Yoshihide Kawasaki, Akihiro Ito, Hisanobu Adachi, Yoshiyuki Kojima, Wataru Obara, Tomonori Habuchi, Hiroyuki Nishiyama, Chikara Ohyama, Norihiko Tsuchiya
Superior detection of significant prostate cancer by transperineal prostate biopsy using MRI-transrectal ultrasound fusion image guidance over cognitive registration
Masaya Ito, Ichiro Yonese, Masahiro Toide, Shuzo Ikuta, Shuichiro Kobayashi, Fumitaka Koga
Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer
Shoko Kitazawa, Tatsuyuki Chiyoda, Kohei Nakamura, Kensuke Sakai, Tomoko Yoshihama, Hiroshi Nishio, Yusuke Kobayashi, Takashi Iwata, Kouji Banno, Wataru Yamagami, Hiroshi Nishihara, Daisuke Aoki
Advantages and limitations of estrogen replacement therapy on hypogonadal survivors of childhood cancer
Miwa Nakamura, Takashi Ohba, Rumi Sasaki, Fumitaka Saito, Munekage Yamaguchi, Takeshi Motohara, Hiroyo Mabe, Xi Lu, Hidetaka Katabuchi, Eiji Kondoh